A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
Clinical trial NCT01479595 · COMPLETED
Trial details
- NCT number
- NCT01479595
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2015-02-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.